BioDot, Inc
Simon Thacker has a diverse work experience spanning over several years. Simon began their career in 1991 as a Research and Development Scientist at Reckitt & Colman and later joined SmithKline Beecham as a Scientist in 1999. In 2000, they worked as an Applications/Sales Engineer at Sotax. In 2006, they joined BioDot, Inc as a Product Specialist, where they conceptualized validation protocols, assisted customers with method development, and participated in sales and support functions. Simon then progressed to the role of European Support Manager and General Manager (EMEAR) at BioDot, responsible for strengthening the brand, modernizing engineering and technical support functions, and managing the overall operations. Currently, Simon Thacker serves as the Managing Director (EMEAR) at BioDot.
Simon Thacker obtained their Higher National Certificate (HNC) in Chemistry from the University of Hull, where they studied from 1994 to 1997. Simon later pursued their Master of Business Administration (MBA) in Business at The Open University, graduating between 2008 and 2012.
This person is not in any offices
BioDot, Inc
For over 25 years, BioDot has developed proprietary, quantitative technologies for the dispensing of low volumes of fluids (picoliter to microliter) that meet the needs of industrial, life science, diagnostic, and medical products. BioDot is division of ATS Automation - Life Sciences Division On March 24, 1994, BioDot established itself as a company in Southern California with its patented BioJet™, "Drop on Demand", non-contact, dispensing technology. At that time, BioDot focused on using this technology to dispense discrete drops, or a series of drops to form a line. This quantitative, enabling technology was used predominantly in Lateral Flow Test or Flow Through Test applications in the diagnostic marketplace. Over the following years, BioDot expanded its expertise outside of dispensing, and developed lamination and cutting technologies. In parallel, it expanded its application abilities to enable scientists to utilize the quantitative dispensing and develop more sophisticated point of care tests, such as: - Glucose or other Microfluidic Sensors - Immunoblots or Allergy Tests - Cell, DNA, or Protein Arrays - Compound Handling In addition, BioDot developed modular workstations and enabled customers to work in either a "Batch" or "In-Line" Approach, depending on their materials and processes, as well as short and long goals. Now, in our 25th year, BioDot continues to be a leading supplier of system tools for the research, development and commercialization of diagnostic tests. With our continuously expanding product portfolio, BioDot has marketed systems for the development and manufacture of Microfluidics. We also have systems for the Life Sciences and the Molecular & Point of Care Diagnostics. By expanding our global presence with entities in China and the UK/Europe, BioDot has a commitment to fully understand our customer's requirements, globally. #lateralflow, #biosensor, #labonachip, #biochip, #dispensing